Adverse Long-Term Outcomes and an Immune Suppressed Endotype in Sepsis Patients with Reduced Interferon-γ ELISpot: A Multicenter, Prospective Observational Study
Evan A. Barrios, Monty B. Mazer, Patrick McGonagill, Christian B. Bergmann, Michael D. Goodman, Robert W. Gould, Mahil Rao, Valerie Polcz, Ruth Davis, Drew Del Toro, Marvin Dirain, Alexandra Dram, Lucas Hale, Mohammad Heidarian, Tamara A. Kucaba, Jennifer P. Lanz, Ashley McCray, Sandra Meszaros, Sydney Miles, Candace Nelson, Ivanna Rocha, Elvia E Silva, Ricardo Ungaro, Andrew Walton, Julie Xu, Leilani Zeumer-Spataro, Anne M. Drewry, Muxuan Liang, Letitia E. Bible, Tyler Loftus, Isaiah Turnbull, Philip A. Efron, Kenneth E. Remy, Scott Brakenridge, Vladimir P. Badovinac, Thomas S. Griffith, Lyle L. Moldawer, Richard S. Hotchkiss, Charles C. Caldwell
medRxiv 2023.09.13.23295360; doi: https://doi.org/10.1101/2023.09.13.23295360
